April 30, 2018 07:54 AM EDTUpdated 08:14 AM
People

Who’s the top earn­ing CEO in bio­phar­ma? Mar­tine Roth­blatt once again hits top slot with $37M pay pack­age

John Carroll

Editor & Founder

For­get Al­ler­gan CEO Brent Saun­ders’ hefty $33 mil­lion pay pack­age for 2017. Ian Read, you and your $28 mil­lion Pfiz­er deal, com­plete with $1 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

No­vo and Viking present new MASH da­ta, but an­a­lysts re­main con­fi­dent in Madri­gal's Rezd­if­fra

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times